Trial intelligence / Profile preview

Safety evaluation of frozen PRP for thumb carpometacarpal osteoarthritis

jRCTc030230742Suspended

Start
Oct 2024
Countries
1
01

Overview

Open-label, single-arm trial of platelet-rich plasma in Rhizarthrosis. Primary endpoint: Safety of regenerative medical technology using frozen PRP cell-processing products. Started Oct 2024; status: suspended.

02

Drugs

platelet-rich plasma
03

Conditions

Rhizarthrosis

Beyond the preview

Go deeper on jRCTc030230742.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTc030230742.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call